再生障碍性贫血

zài shēng zhàng ài xìng pín xiě
  • aplastic anemia
再生障碍性贫血再生障碍性贫血
再生障碍性贫血[zài shēng zhàng ài xìng pín xiě]
  1. 采用放免分析法测定68例不同类型再生障碍性贫血患者血清叶酸和维生素B(12)含量。

    The serum folic acid and vitamin B12 were determined in 68 cases of various type of aplastic anemia by radioimmunoassay .

  2. 再生障碍性贫血(AA)严重危害人类健康。

    Aplastic anemia ( AA ) is severely harmful to the health of mankind .

  3. 再生障碍性贫血患者DNA损伤修复活性检测

    DNA repair in patients with aplastic anemia

  4. 非亲缘HLA不相合脐血移植治疗再生障碍性贫血

    Successful unrelated HLA-mismatched cord blood transplantation in a patient with severe aplastic anemia

  5. 单克隆抗体CD4及CD8联合环孢素A治疗重型再生障碍性贫血临床研究

    A clinical trial of anti-CD_4 CD_8 monoclonal antibodies combined with cyclosporine A in treatment of severe aplastic anemia

  6. 川芎嗪对免疫介导再生障碍性贫血小鼠骨髓细胞CD(34)抗原表达的影响

    Effect of Ligustrazine on CD_ ( 34 ) Antigen Expression of Bone Marrow Cells in Immune-Mediated Aplastic Anemia Mice

  7. CD(55)、CD(59)分子在慢性再生障碍性贫血肾阳虚证患者中的表达观察

    Expressions of CD_ ( 55 ) and CD_ ( 59 ) in Patients with Chronic Aplastic Anemia of Kidney-Yang Deficiency

  8. 应用单克隆抗体-免疫磁珠分离系统分离纯化再生障碍性贫血骨髓CD(34)~+细胞

    Separating and Purification Bone Marrow CD_ ( 34 ) ~ + Cells in Aplastic Anemia with Monoclone Antibody-immunomagnetic Beads System

  9. 4急性白血病(AL)组无效输注率15.1%,再生障碍性贫血(AA)组46.2%。

    The PTR was 15.1 % in leukemia group and 46.2 % in aplastic anemia ( AA ) group .

  10. DNA末端原位标记技术研究慢性再生障碍性贫血骨髓CD(34)~+细胞凋亡

    Study on Apoptosis of Bone Marrow CD_ ( 34 ) ~ + Cells in Chronic Aplastic Anemia Patients by DNA in Situ End Labelling

  11. 目的探讨老年人再生障碍性贫血(AA)的临床特点。

    Objective To analyse the clinical features of aged patients with aplastic anemia ( AA ) .

  12. 抗T细胞单克隆抗体对再生障碍性贫血患者TNF和IL-2水平的影响

    The effect of anti human T lymphocyte monoclonal antibody on TNF and IL 2 level in aplastic anemia patients

  13. 补肾泻肝方治疗再生障碍性贫血临床疗效与IFN-γmRNA基因表达关系的研究

    Clinical therapeutic effects of tonifying kidney and purging liver recipe on aplastic anemia and its relation to gene expression of IFN - γ mRNA

  14. HLAⅡ类单体型DRB11501与再生障碍性贫血

    A HLA Class ⅱ Haplotype of DRB_11501 and Aplastic Anemia

  15. 再生障碍性贫血与ABO血型的关系

    The Relation Between Aplastic Anemia and ABO Blood Group

  16. 再生障碍性贫血(AA)是由多种因素导致的主要表现为骨髓造血功能衰竭的一种疾病。

    Aplastic Anemia ( AA ) is characterized by bone marrow failure and its exact cause is still unknow .

  17. 补肾化痰活血中药对再生障碍性贫血小鼠骨髓CD(34)~+和细胞因子表达的影响

    Effect of Kidney-invigorating , Sputum-eliminating and Blood-activating Drugs on Expression of Cytokines and Bone Marrow CD_ ( 34 ) ~ + in Aplastic Anemia Mice

  18. 再生障碍性贫血患儿C-kit基因表达及其意义

    Expression and significance of C-kit gene in children with aplastic anemia

  19. 参麦注射液对慢性再生障碍性贫血患者血清肿瘤坏死因子及骨髓CD(34)~+细胞凋亡的影响

    Influence of Shenmai injection on blood serum tumor necrosis factor and bone marrow CD_34 ~ ( + ) cell 's apoptosis of chronic aplastic anemia patient

  20. 抗人CD3T淋巴细胞单克隆抗体治疗重型再生障碍性贫血的初步观察

    A preliminary experience of treatment of severe aplastic anemia with murine anti-human CD_3 T lymphocyte monoclonal antibody

  21. SCF在儿童再生障碍性贫血治疗中具有良好的临床应用前景。

    ( 3 ) SCF may be of therapeutic value in children with aplastic anemia .

  22. 再生障碍性贫血患者血清Epo、Tpo水平及其临床意义

    The level of serum Epo 、 Tpo in aplastic anemia and its clinical implication

  23. 补肾泻肝方对再生障碍性贫血外周血IFN-γ、IL-2的影响

    The Influence of the Prescription which Nourishes Kidney and Clears the Livers of Pathogenic Fire on Peripheral Blood of Aplastic Anemia

  24. 再生障碍性贫血和骨髓增生异常综合征患者骨髓CD(34)~+细胞及其表面的粒细胞&巨噬细胞集落刺激因子受体测定

    The Determination of CD34 Positive Cells and Granulocyte-Macrophage Colony-Stimulating Factor Receptors on CD34 Positive Cells in Bone Marrow of the Patients with Aplastic Anemia and Myelodysplastic Syndrome

  25. 苯中毒再生障碍性贫血患者骨髓细胞免疫功能和Fas、CD34抗原变化

    Alteration of Fas and CD34 antigen expression and cellular immune function in patients with aplastic anemia caused by benzene poisoning

  26. GM-CSF及血象三系水平变化在妊娠合并再生障碍性贫血中的意义

    The significance of GM-CSF and change of hemogram levels in pregnancy complicated with aplastic anemia

  27. 本文测定28例小儿再生障碍性贫血外用血T淋巴细胞亚群以及血清可溶性白细胞介素α受体(SIL-2R)。

    T-cell group and SIL-2R in 28 children patients with aplastic anemia were detected .

  28. 慢性再生障碍性贫血不同肾虚证型患者血清TGF-β1与IL-1β表达比较

    Comparison of Serum TGF - β 1 and IL-1 β Expressions Between Different Kidney-Deficiency Syndromes in Patients with Chronic Aplastic Anemia

  29. 目的:研究免疫活性分子异常在再生障碍性贫血(AA)发病中的作用及临床意义。

    Objective : To investigate the effect of immunologic molecules in development of aplastic anemia ( AA ) and its clinical significance .

  30. 对其它疗法效果不佳的再生障碍性贫血、MDS,CSF疗效确切且副作用轻微。

    For aplastic anaemia and MDS , the therapeutic effects of CSF are definite , and its side-effects are mild .